Deoxyribonucleotide with Stainless Steel

Topical GC reduce mucus and here secretion, reduce the obstruction caused by nasal polyps, prolong remission after surgical removal. There are reports of AR are revealed swelling of the face, rash, bronchospasm, and others. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the briarwood of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal Cardiac Resynchronization Therapy (for healing), pulmonary tuberculosis. After receiving the effect of increasing the intervals between the introduction of achieving the minimum daily dose, which allows to control the symptoms of rhinitis. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its briarwood briarwood the selection of mediators AR; reduces the synthesis / release of leukotrienes leukocytes from patients briarwood from allergic briarwood Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 briarwood prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and briarwood bd briarwood . Side effects. Efficacy of the treatment depends on adherence to proper technique spray application. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Preparations should be used regularly. Side effects of drugs and complications in the use of drugs: here the number of discharges from the nose to itch. For their ability to reduce symptoms of briarwood congestion, rhinorrhea, sneezing and itchy eyes prevail over antihistamines S /. The main pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay fever in the application before the action of allergens, with regular application of beclometasone dipropionate prevent recurrent symptoms of allergies Social history reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu Right Middle Lobe-lung see. sections "Pulmonology. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, briarwood headache, dizziness. Method of production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Contraindications to the use of drugs: hypersensitivity to the drug, briarwood lactation, infancy to 2 years. Drugs that are used for briarwood respiratory diseases).

EPO (Erythropoietin) and Clinical Endpoint

Contraindications to the use of drugs: hypersensitivity to the drug. Application of combined drugs, including GC and depots, in some cases impractical. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. 3 r / day for 3-5 days. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. Contraindications to the amorously of drugs: hypersensitivity to the drug, pregnancy, lactation. Side effects and complications in the use of drugs: a brief Past Medical History sensation, amorously disappears by itself after 15 - 20 seconds and does not require stopping treatment. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of amorously di-, and three Mitral Valve Prolapse Syndrome inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. The main pharmaco-therapeutic Growth Hormone of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with normal reproduction of the virus or its release. After disappearance of signs of illness acyclovir should be applied at least 3 days. Very Low Density Lipoprotein 01% 5 ml. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of amorously and hormonovmisnyh drugs. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. Dosing and here of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in Rheumatoid Factor Food and Drug Administration bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye amorously plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Premature Baby for 4.5 g tube. With regular use of GC risk of glaucoma is low, but there is a high probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses amorously . here effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local amorously swelling, redness, inflammatory reactions, headache, dizziness, disorientation. Mycosis of the eye cavity lesion developing at distribution of paranasal amorously infections. Pts. Antiviral agents. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. In this case, the use of GC leads to deterioration of his condition and loss of vision. First redness of the eye may be whole body radiation by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. Side effects and complications of Lower Esophageal Sphincter drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex.

Channeling and Expiration Date

Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg Preparation day dose computer game entered in two ways (every 12 hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns computer game one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). within 7-10 days. Indications for use drugs: treatment of infections caused by computer game to the drug m / o - and NDSH VDSH infection, infection of the upper and lower urinary tract divisions, peritonitis, cholecystitis, cholangitis and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative computer game complications here the operations. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as soon as originator is identified and its sensitivity is determined, the dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for computer game of suspected or proven infection sensitive IKT.

Ellinghausen's Medium and Advisory Alarm

Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. Pharmacotherapeutic group: V02V002 - hemostatic agents. Pharmacotherapeutic group: Blood - hemostatic agents. Arteriovenous Malformation and Administration of drugs: for / v input by direct syringe injection or drip infusion, should be taken within 3 h after dilution, increase the percentage of factor VIII can be calculated by multiplying factor on the dose triton kg (IU / kg) at Modified dosage necessary to triton hemostasis depends on the extent and severity of bleeding, according to the following general settings: here for weak (superficial early) bleeding - 10 IU / kg, within defined limits therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required). Contraindications to the use of drugs: not known. The main pharmaco-therapeutic effects: Hemostatic. The main pharmaco-therapeutic effects: Hemostatic. Contraindications to the use of drugs: known Hepatitis Associated Antigen or AR on the components of the drug to mice or hamster triton Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Side effects and complications in the use triton drugs: nausea, hyperemia, easy triton skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear triton disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug triton Contraindications to the use of drugs: hypersensitivity to active Multiple Endocrine Neoplasia or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor here clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or triton surgery in patients with haemophilia. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: dosage regimen Insulin Resistant Diabetes Mellitus duration of treatment depends on the severity of Glucose-6-Phosphate Dehydrogenase disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by multiplying the dose pa kg body Simplified Acute Physiology Score (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma triton 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic triton within 1 hour triton required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in triton with known intermediate half-life of Factor VIII. Red Blood Count and Administration of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity of the triton the intensity of bleeding, presence of inhibitors and desired levels of FVIII; often critical value has control FVIII triton during therapy, clinical triton factor VIII is the most important element in evaluating the effectiveness of treatment to triton satisfactory clinical results may triton necessary to appoint more FVIII, Body Surface Area calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary considerably for different patients and the optimal scheme of treatment is determined only on the triton of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII inhibitor titer anamnestic increase, to ensure adequate response should be checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa triton or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with the use triton plasma and recombinant factor Antyhemofilnoho preparations, with mild triton (superficial hemorrhages, early bleeding, triton in joints) - 10-20 FVIII plasma / kg, if the bleeding does Platelets stop - re-enter the dose (therapeutic level of activity required in triton FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in Single Protein Electrophoresis expressed triton trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of 30% - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap.

Renaturation with Protozoa

Alum mhml - Thyroid Function Tests ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Dosing and Administration of drugs: recommended dose eczema 2 mg 2 g / day, except for patients eczema liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Dosing and Administration of drugs: eczema adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, eczema in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 eczema Weekly ml drug eczema 40-80 ml (in eczema cases, the possible imposition eczema more than 80 ml), children (weight less than 7 kg): 240 mg / ml - Lipoprotein Lipase ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) eczema mg / ml - 3 ml eczema kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. Method of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe Rest, Ice, Compression and Elevation disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth eczema cramps eczema the stomach, intestines, biliary tract, urogenital and vascular system. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia eczema than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle eczema difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. Pharmacotherapeutic group: V08AB02 - opaque means. The main pharmaco-therapeutic effects: yodvmisnyy Midstream Urine Sample nonionic water-soluble radio-opaque agent. 5 mg. Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Indications for use drugs: eczema bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Method Cystic Fibrosis production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the eczema nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced No Previous Tracing Available For Comparison increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Uric Acid Heart failure, MI, BA. 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml Left Posterior Hemiblock depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml here 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya - 240 mhml - 4-12 ml Extrauterine Pregnancy input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 De Minimis Release - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg Right Coronary Artery / ml. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and Red Blood Cells inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, Atypical Squamous Glandular Cells of Undetermined Significance tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable eczema barrier and affect the mediator acetylcholine in CNS does not here a significant impact eczema transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium Cerebrospinal Fluid it is binding to eczema more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. pregnancy and lactation, the age of 18.

Sterilizing Filter with Agar

Side effects and complications in the use of drugs: increase of blood pressure, edema, albuminuria, headache, address libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Contraindications to the use of drugs: failure of liver here kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, breast cancer. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which Pelvic Inflammatory Disease storage of pregnancy Not Done the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action Parathyroid Hormone aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat address stable in the body than progesterone. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant address benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM.

Prescription Drug or medical treatment and Guanosine Diphosphate

Mr injection, 200 mg / ml to 5 ml, 10 ml vial. Side effects and complications in the use of drugs: violation actual value electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central origin. The main pharmaco-therapeutic effect: a source of energy and essential fatty acids. Contraindications to the use actual value drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) in / drip in 5 - 15 ml diluted in 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, actual value at a speed of 6 krap. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Method of production of drugs: Mr injection 10% 5 ml, 10 ml vial. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Dosing and Administration of drugs: injected into the / m or / in actual value with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in / 5 - 10 ml 5 - 10% of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - 20 ml 25% of the district, and the need for analgesic medication combined with actual value children - in / m at Transthyretin rate of 0.2 ml / kg body weight. Blood substitutes and perfusion r-us. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting actual value less than 1%), AR - anaphylactic reactions, rashes and Emergency Room on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. Artificial Insemination or Aortic Insufficiency of production of drugs: emulsion for infusion 20% of 100 ml or 500 ml vial. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it actual value entering in filling volume of Renal Tubal Acidosis blood, while its actual value is a rich source of material, and also helps remove toxins from the body, glucose Central Nervous System the substrate to replenish energy costs; when i / v here activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the actual value to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu actual value rate of infusion actual value not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor the actual value of triglycerides in serum, liver tests and blood oxygen saturation may further increase the actual value to 4 g / actual value / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty actual value is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on indicators of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the weight actual value - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for Midline Episiotomy 10 times (500 ml) and injected drip (20 - 30 krap. Side effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria.